Delivery Order SPE2DB22D3301-SPE2DB25FY5PC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with a completion deadline of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials, valued at $10,916.78, with a completion date of July 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $21,833.56 to AmerisourceBergen Drug Corp for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) 600-600 mg in 10 mL unit doses totaling 20,000 units. The contract, awarded on September 16, 2025, with an ultimate completion date of October 7, 2025, utilizes firm fixed pricing under a non-competitive delivery order structure. This order will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $21,833.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials), with an ultimate completion date of November 10, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $8,225.29 delivery order to AmerisourceBergen Drug Corp for PHESGO (pertuzumab, trastuzumab, and hyaluronidase-oysk), a specialty pharmaceutical product used in cancer treatment. The delivery order, issued on August 6, 2025, calls for 30,000 units of the 1,200-600 mg/15mL formulation with an ultimate completion date of August 27, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 5, 2025, valued at $21,833.56 for PHESGO 600-600MG 1S pharmaceutical products. This is a firm fixed-price, non-set-aside contract funded by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of October 2, 2025. The delivery order is performance location is Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $21,435.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PHESGO 600-600 MG-20,000 UNIT 10ML. Amerisourcebergen Drug Corporation will deliver the contracted pharmaceutical products to a location in Conshohocken, Pennsylvania by August 29, 2023 in support of the Defense Logistics Agency's medical supply chain programs. As the prime contractor, Amerisourcebergen Drug Corporation will perform the order itself without involvement from...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 600-600 mg - 20,000 unit 10 ml of the pharmaceutical product PHESGO. The award, valued at $21,283.68, has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under any set-aside designation. This delivery order is part of a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $10,641.84 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 20,000 units of the drug PHESGO 600-600 MG in 10 ML vials, with a completion date of July 10, 2024. This order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY5PCDelivery Order
The Defense Logistics Agency awarded a $10,916.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10 mL vials. This is an unset-aside, competitively awarded contract with a completion date of June 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order represents a child contract issued against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. PHESGO is a combination breast cancer treatment used in oncology care within military healthcare systems. The delivery order reflects the ongoing pharmaceutical supply operations under DLA's comprehensive medical supply chain, which leverages AmerisourceBergen's broad portfolio of brand-name medications, generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. As the prime contractor on the DLA Troop Support Medical IDC, AmerisourceBergen continues to support Defense Health Agency requirements and other federal healthcare customers through this flexible contract vehicle, with performance occurring at the company's Conshohocken, Pennsylvania location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 6/2/25 |